Dihydroergotoxine Mesylate Extended-Release Tablets specific how long to take the instructions are not strictly prescribed, need to be based on the patient’s condition and physical condition to assess the duration of the medication. Clinically, the dosage of 2~4 weeks is usually prescribed first, and if the efficacy is good, the prescription can be extended appropriately after evaluation by the doctor.
Dihydroergotoxine Mesylate Extended-Release Tablets is a prescription drug mainly used for the sequelae of cerebrovascular disease, Alzheimer’s disease and so on. Different patients have different degrees of tolerance to the drug and different dosing times. If the effect is significant and the condition is stable after 2~4 weeks of medication, the prescription amount can be extended appropriately; if the effect is not significant after 4 weeks of medication, the medication may need to be replaced.
Dihydroergotoxine mesylate extended-release tablets in the initial period of drug use occasionally nausea, vomiting, stomach upset, postural hypotension and other adverse reactions, the drug should pay attention to monitoring blood pressure. Hypotension, severe bradycardia, cardiac organic damage, renal hypoplasia and other patients and pregnant women should be prohibited dihydroergotoxine mesylate extended-release tablets.
Patients should use the drug under the guidance of a doctor, and should not stop taking the drug at will, otherwise the efficacy will be affected.